Definium Therapeutics develops psychedelic-based therapeutics for psychiatric and neurological disorders. Backed by North Carolina Biotechnology Center.
About the role
Together we are moving psychiatry forward—beyond better, into a boundless future. Join us! The Senior Director, National Accounts implements Definium’s market access strategy across assigned commercial payer and PBM accounts and develops account-specific recommendations to support patient access and reimbursement. This role focuses on commercial national accounts and excludes Medicaid and other government accounts.
What they're looking for
- Bachelor's degree required, advanced degree preferred
- Minimum 10 years of market access, payer, reimbursement, account management, or related biopharmaceutical experience
- Demonstrated experience with national commercial health plans, PBMs, and/or large regional payer accounts
- Experience in CNS, psychiatry, mental health, behavioral health, or other specialty product launches preferred
- Track record implementing market access strategies and achieving account-specific access objectives
- Understanding of payer policy, reimbursement, benefit design, formulary management, and coverage decision-making
More about this role
Definium Therapeutics is a late-stage clinical biopharmaceutical company and our mission is to forge a new era of psychiatry by applying scientific rigor to psychedelics, with the goal of developing accessible treatments that unlock healing at scale.
Our lead product candidate, lysergide tartrate (our proprietary orally disintegrating tablet form of lysergide (LSD) D-tartrate), represents a highly differentiated, potential best-in-class opportunity for patients suffering from generalized anxiety, major depressive disorder, and posttraumatic stress disorder. Our early stage pipeline includes DT402, the R-enantiomer of MDMA and is under development to target the core symptoms of autism spectrum disorder (ASD), specifically addressing social communication challenges.
Guided by the recognition that patients deserve more than better, Definium is relentlessly advancing a new generation of therapeutics intended to address the underlying causes of psychiatric and neurological disorders. By turning evidence into impact, Definium aims to change the trajectory of today’s mental health care crisis and enable a healthier future. Headquartered in New York, Definium Therapeutics trades on Nasdaq...
Browse similar: Startup jobs · Remote jobs